Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction

AIM: Sacubitril valsartan (SV) has revolutionized disease history in patients with heart failure and reduced ejection fraction (HFrEF). Our study assessed SV impact on clinical and echocardiographic parameters in HFrEF outpatients previously treated with optimized therapy. METHODS: Forty-nine HFrEF...

Descripción completa

Detalles Bibliográficos
Autores principales: Landolfo, Matteo, Piani, Federica, Esposti, Daniela Degli, Cosentino, Eugenio, Bacchelli, Stefano, Dormi, Ada, Borghi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586107/
https://www.ncbi.nlm.nih.gov/pubmed/33134479
http://dx.doi.org/10.1016/j.ijcha.2020.100656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586107/
https://www.ncbi.nlm.nih.gov/pubmed/33134479
http://dx.doi.org/10.1016/j.ijcha.2020.100656

Ejemplares similares